Filtros de búsqueda

Lista de obras de John Wagstaff

A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour

artículo científico publicado el 1 de enero de 1992

A method for following human lymphocyte traffic using indium-111 oxine labelling

artículo científico publicado en 1981

A method for studying the dynamics of the primary migration of human lymphocytes using Indium-iii oxine cell labelling

artículo científico publicado en 1982

A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphoma

artículo científico publicado en 1984

A phase I toxicity study of human rDNA interferon in patients with solid tumours

article

A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma

artículo científico publicado en 2002

A phase II study of human rDNA alpha-2 interferon in patients with low grade non-Hodgkin's lymphoma

scientific article published on 01 January 1986

A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2.

artículo científico publicado en 1994

A progress report of a phase I study of interferon-gamma and interleukin-2 and some comments on the mechanism of the toxicity due to interleukin-2

artículo científico publicado en 1989

A prospective study of the treatment of high-grade histology non-Hodgkin's lymphoma involving the gastrointestinal tract

artículo científico publicado en 1985

A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO).

artículo científico publicado en 2013

A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group

artículo científico publicado en 1984

A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update.

artículo científico publicado en 2013

A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease

artículo científico publicado en 1984

A randomized trial of two types of adjuvant chemotherapy in radiotherapy-treated patients with clinical stages I and II high-grade non-Hodgkin's lymphoma

artículo científico publicado en 1987

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

artículo científico publicado en 2017

Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.

artículo científico publicado en 2017

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

artículo científico publicado en 2015

Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart review

artículo científico publicado en 2013

Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2).

artículo científico publicado en 1992

Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors.

artículo científico publicado en 2006

CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma

artículo científico publicado en 2017

Clinical use of interferon alfa-2b (intron-A): the Manchester experience

artículo científico publicado en 1987

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

artículo científico publicado en 2015

Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer.

artículo científico publicado en 1988

Complement activation and high-dose of interleukin-2

scientific article published on 01 August 1989

Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously

artículo científico publicado en 1996

Corynebacterium parvum followed by chemotherapy (actinomycin D and DTIC) compared with chemotherapy alone for metastatic malignant melanoma

artículo científico publicado en 1986

Culture of tumour-infiltrating lymphocytes from melanoma and colon carcinoma: Removal of tumour cells does not affect tumour-specificity

artículo científico publicado en 1995

Dendritic cells: a novel therapeutic modality

artículo científico publicado en 1999

Determination of capillary leakage due to recombinant interleukin-2 by means of noninvasive conductivity measurements

scientific article published on 01 January 1993

Dose-intensive chemotherapy with doxorubicin, cyclophosphamide and GM-CSF fails to improve survival of metastatic breast cancer patients

artículo científico publicado en 1996

Effect of in vivo administration of interferon gamma on expression of MHC products and tumour associated antigens in patients with metastatic melanoma

artículo científico publicado en 1989

Effect of suramin on adenylate cyclase and protein kinase C.

artículo científico publicado en 1994

Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer

artículo científico publicado en 1997

Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours

artículo científico publicado el 1 de noviembre de 1993

Endocrine tumors

artículo científico publicado en 1990

Epstein-Barr Virus-Positive Mucocutaneous Ulcers Complicate Colitis Caused by Immune Checkpoint Regulator Therapy and Associate With Colon Perforation

scientific article published on 11 October 2019

Factors affecting remission and survival in patients with advanced Hodgkin's disease treated with MVPP

artículo científico publicado en 1986

Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment.

artículo científico

Health-related quality of life results from the phase III CheckMate 067 study.

artículo científico publicado en 2017

High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.

artículo científico publicado en 2003

Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observations

scientific article published on 01 March 1981

Hypotension induced by interleukin-3 in patients on angiotensin-converting enzyme inhibitors

scientific article published on 01 February 1995

IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer

scientific article published on 01 January 1996

Ibandronate reduces endogenous reactive oxygen species levels in cultured prostate cancer and endothelial cells.

artículo científico publicado en 2009

Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countries

artículo científico publicado en 2014

Infiltrating lobular carcinoma of the breast: Response to endocrine therapy and survival

article

Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy.

artículo científico publicado en 1994

Interferon and cancer.

artículo científico publicado en 1984

Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia

artículo científico publicado en 1992

Interleukin-2 therapy and blockage of double-lumen catheters

scientific article published on 01 April 1989

Interleukin-2 therapy does not exacerbate multiple sclerosis

scientific article published on 01 August 1997

Interleukin-6 downregulates factor XII production by human hepatoma cell line (HepG2).

artículo científico publicado en 1997

Intermittent high-dose cyclophosphamide with and without prednisolone: a study of the relationships between toxicity, response and survival in metastatic lung cancer

artículo científico publicado en 1982

Is there a role for ibandronate in the treatment of prostate cancer patients with bony metastases?

scientific article published on January 2009

Lobular panniculitis after subcutaneous administration of interleukin-2 (IL-2), and its exacerbation during intravenous therapy with IL-2.

artículo científico publicado en 1992

Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients

scientific article published on 01 November 1997

Lymphocyte migration in malignant disease

artículo científico publicado el 1 de marzo de 1983

Lymphokines and cytokines

scientific article published on 01 January 1991

Lymphokines and cytokines

artículo científico publicado en 1987

Lymphokines and cytokines.

artículo científico publicado en 1988

Management of high-grade non-Hodgkin's lymphoma in adults.

artículo científico publicado en 1987

Management of stage III breast cancer.

artículo científico publicado en 1998

Metastatic unknown primary tumour presenting in pregnancy: a rarity posing an ethical dilemma

scientific article published on August 2007

Metronomic administration of ibandronate and its anti-angiogenic effects in vitro.

artículo científico publicado en 2009

Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer

scientific article published on 01 January 1984

Molecular Imaging and Biological Evaluation of HuMV833 Anti-VEGF Antibody: Implications for Trial Design of Antiangiogenic Antibodies

artículo científico publicado en 2002

Mucin-1-related T cell infiltration in colorectal carcinoma

scientific article published on 01 July 1996

Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer

artículo científico publicado en 1997

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

artículo científico publicado en 2015

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial

artículo científico publicado en 2020

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

artículo científico publicado en 2017

Phase I clinical trial of methylene dimethane sulfonate.

artículo científico publicado en 1987

Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer

scientific article published on 22 January 2005

Phase I study on the sequential administration of recombinant human interferon-gamma and recombinant human interleukin-2 in patients with metastatic solid tumors

artículo científico publicado en 1991

Phase II study of interferon-gamma and interleukin-2: tachyphylaxis of toxicity to the liver during increasing immune enhancement

artículo científico publicado en 1993

Phase II study of vindesine infusion in visceral metastatic malignant melanoma

artículo científico publicado en 1983

Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor

artículo científico publicado en 1987

Primary carcinoma of the fallopian tube: favourable response to new chemotherapeutic agent, CHIP.

artículo científico publicado en 1985

Primary leiomyosarcoma of the rectum: report of two cases and review of the literature.

artículo científico publicado en 1989

Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer

artículo científico publicado el 1 de febrero de 1998

Progressive supra-nuclear palsy

scientific article published on 01 May 1981

Reduced expression of distinct T-cell CD molecules by collagenase/DNase treatment

scientific article published on 01 April 1994

Renal cell cancer: is immunotherapy dead?

artículo científico publicado en 2007

Renal cell carcinoma and interleukin-2: a review.

artículo científico publicado en 1995

Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients

scientific article published on 01 August 2000

Studies on the contact system of coagulation during therapy with high doses of recombinant IL-2: implications for septic shock

artículo científico publicado en 1991

Suramin: rapid loading and weekly maintenance regimens for cancer patients

artículo científico publicado el 1 de noviembre de 1992

Surgery and radiotherapy in the treatment of primary carcinoma of the Fallopian tube--report of 18 cases

artículo científico publicado en 1985

Swelling of metastatic tumors with high-dose interleukin therapy

artículo científico publicado en 1988

T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma.

artículo científico publicado en 1997

Tamoxifen in the treatment of metastatic malignant melanoma

artículo científico publicado en 1982

Teams Talking Trials: results of an RCT to improve the communication of cancer teams about treatment trials

artículo científico publicado en 2013

The "hot spleen" phenomenon in metastatic malignant melanoma: its incidence and relationship with the immune system.

artículo científico publicado en 1982

The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2.

artículo científico publicado en 1992

The antiangiogenic properties of bactericidal/permeability-increasing protein (BPI).

artículo científico publicado en 2002

The behavior of autologous indium-114m-labeled lymphocytes in patients with lymphoid cell malignancy

scientific article published on 01 April 1988

The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast

artículo científico publicado en 1988

The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models.

artículo científico publicado en 2002

The migratory properties of indium-111 oxine labelled lymphocytes in patients with chronic lymphocytic leukaemia

artículo científico publicado en 1981

The release of interleukin-8 during intravenous bolus treatment with interleukin-2

scientific article published on 01 December 1994

The role of biological response modifiers in the management of patients with colorectal cancer

artículo científico publicado el 1 de julio de 1995

Therapeutic vaccines for cancer: an overview of clinical trials

artículo científico

Therapy with interleukin-2 induces the systemic release of phospholipase-A2

artículo científico publicado en 1995

Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025.

artículo científico

Treatment of relapsed non-Hodgkin's lymphoma with a combination of hydroxyurea, ifosfamide, and etoposide

artículo científico publicado en 1985

Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry.

artículo científico publicado en 2015

Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study

artículo científico publicado en 2014

Treatment with tumour infiltrating lymphocytes and interleukin-2 in patients with metastatic melanoma: a pilot study

artículo científico publicado en 1992

Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression

artículo científico publicado en 2003

Tumour-induced hypoglycaemia: a case report

artículo científico publicado en 1994

UK guidelines for the systemic treatment of renal cell carcinoma.

artículo científico publicado en 2009

Workshop on suramin with emphasis on prostate cancer: re-evaluation of response criteria

artículo científico publicado en 1993

[Angiogenesis and the regulation of antitumor defense]

artículo científico publicado en 1999

[Primary high-dose chemotherapy with hematopoietic growth factors followed by surgery and radiotherapy in stage III breast carcinoma; a Phase II study in 15 patients]

artículo científico publicado en 1994

[The application of hematopoietic growth factors in oncology]

artículo científico publicado en 1991